Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-09
2011-12-06
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S362000, C424S009100
Reexamination Certificate
active
08071546
ABSTRACT:
The present invention is directed to uses of PEGylated albumins which include methods of treating reduced functional capillary density, reduced blood volume, septic shock and cardiac arrhythmia in a subject, which comprise administering to the subject a therapeutically effective amount of a PEGylated albumin.
REFERENCES:
patent: 5585484 (1996-12-01), Acharya et al.
patent: 5750725 (1998-05-01), Acharya et al.
patent: 6017943 (2000-01-01), Acharya et al.
patent: 6371975 (2002-04-01), Cruise et al.
patent: 6458147 (2002-10-01), Cruise et al.
patent: 6670323 (2003-12-01), Looker et al.
patent: 6773613 (2004-08-01), Winslow et al.
patent: 6844317 (2005-01-01), Winslow et al.
patent: 6875423 (2005-04-01), Intaglietta et al.
patent: 7019117 (2006-03-01), Acharya et al.
patent: 7038016 (2006-05-01), Talarico et al.
patent: 7144989 (2006-12-01), Acharya et al.
patent: 7169900 (2007-01-01), Acharya et al.
patent: 7271145 (2007-09-01), Winslow et al.
patent: 7501499 (2009-03-01), Acharya et al.
patent: 7521174 (2009-04-01), Acharya et al.
patent: 2003/0009145 (2003-01-01), Struijker-Boudier et al.
patent: 2003/0161809 (2003-08-01), Houston et al.
patent: 2004/0002443 (2004-01-01), Acharaya et al.
patent: 2005/0026816 (2005-02-01), Winslow et al.
patent: 2005/0037966 (2005-02-01), Ruben et al.
patent: 2005/0159339 (2005-07-01), Acharya et al.
patent: 2005/0201988 (2005-09-01), Acharya et al.
patent: 2006/0111275 (2006-05-01), Acharaya et al.
patent: 2009/0215670 (2009-08-01), Acharya et al.
patent: 2009/0298746 (2009-12-01), Acharya et al.
patent: 2010/0216695 (2010-08-01), Acharya et al.
patent: WO 2006/135740 (2006-12-01), None
patent: WO 2007/050121 (2007-05-01), None
Wettstein R et al., entitled “Resuscitation from Hemorrhagic Shock with MalPEG-Albumin: Comparison with MalPEG-Hemoglobin,” Shock, vol. 22, No. 4, 2004, pp. 351-357.
“PCT Notification Concerning Transmittal of International Preliminary Report on Patentability” dated Mar. 19, 2009 issued by The International Bureau of WIPO in connection with PCT International Patent Application No. PCT/US2006/022619, 8 pages, Mar. 19, 2009.
Acharya Seetharama A.
Cabrales Pedro
Manjula Belur N.
Tsai Amy
Albert Einstein College of Medicine of Yeshiva University
Amster Rothstein & Ebenstein LLP
Kam Chih-Min
La Jolla Bioengineering Institute
LandOfFree
Uses of pegylated albumin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of pegylated albumin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of pegylated albumin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295885